Chiron, another pharmaceutical concern, is based in Emeryville, Calif.  Connaught is a biotechnology research and vaccine manufacturing concern.
the proposed acquisition would be of ``net benefit'' to Canada
Institut Merieux's bid for Toronto-based Connaught has run into problems with the Canadian government, which told Merieux last week that it wasn't convinced that the proposed acquisition would be of ``net benefit'' to Canada.
Chiron, another pharmaceutical concern, is based in Emeryville, Calif.  Connaught is a biotechnology research and vaccine manufacturing concern.</s>Institut Merieux's bid for Toronto-based Connaught has run into problems with the Canadian government, which told Merieux last week that it wasn't convinced that the proposed acquisition would be of ``net benefit'' to Canada.</s>the proposed acquisition would be of ``net benefit'' to Canada